c-Met receptor comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-07-06. Where a claim depends on a specific study, the study is described rather than over-claimed.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
Dihexa is a synthetic compound studied in laboratory and animal models for effects on synaptic connectivity and cognitive performance. It is often described as a peptide analog because its structure incorporates amino acid residues linked to a hexanoic acid group. The molecule is not a naturally occurring human hormone or neurotransmitter. Its name appears in research literature and online discussions, but it has not been approved as a medicine by major regulatory agencies. Most information comes from preclinical experiments rather than controlled human trials.
The compound originated from work on angiotensin IV, a peptide fragment of the renin-angiotensin system. Researchers modified angiotensin IV-related structures to produce molecules with altered stability and activity. Dihexa emerged from that effort and was reported to promote dendritic spine growth in cultured neurons. Some studies link its effects to hepatocyte growth factor signaling and the c-Met receptor, while other work points to insulin-regulated aminopeptidase. The precise primary target remains a subject of investigation, and findings may depend on cell type, assay conditions, and species.
In animal research, dihexa has been administered through several routes, and reports describe improved performance on spatial learning and memory tasks in rodents. These results are frequently cited in discussions of nootropic compounds. However, species differences, small sample sizes, and varied testing protocols limit how far the findings can be generalized. No large randomized controlled trials in humans have established efficacy or long-term safety. Claims about human cognitive enhancement therefore remain speculative, and the compound is best described as an experimental laboratory substance rather than a proven therapeutic or supplement.
| Property | Value | Notes |
|---|---|---|
| Chemical name | N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide | Common full name in research literature. |
| Class | Synthetic peptide | Modified angiotensin IV analog. |
| Related compound | Angiotensin IV | Parent peptide fragment. |
| Proposed target | HGF/c-Met pathway | Described as an HGF mimetic; not fully confirmed. |
| Development status | Preclinical research | No widely approved clinical use. |
Dihexa is a synthetic peptide studied in preclinical neuroscience. It is often described as an angiotensin IV analog or derivative. The compound also appears under research codes such as PNB-0408 and N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. It is not an approved drug, and it is not a conventional vitamin or nutrient. In many jurisdictions, material sold as dihexa is handled as a research chemical rather than a medicine or supplement. This classification affects how the material is labeled and distributed.
Chemically, dihexa is a short peptide-like molecule with nonstandard components. Its structure includes tyrosine and isoleucine residues linked to a hexanoic acid group and an aminohexanoic amide segment. This design distinguishes it from endogenous angiotensin IV, though the two are discussed together because of shared origins. Published summaries classify it as a small synthetic peptide with lipophilic features that may influence how it crosses biological barriers in experimental systems. Exact conformational details depend on the specific salt or free base form.
Development of dihexa followed from studies on angiotensin IV analogs and their effects on learning and memory. Researchers sought compounds with improved metabolic stability and brain penetration compared with natural peptides. In preclinical reports, dihexa was associated with changes in synaptic connectivity and performance on spatial tasks. These findings generated interest in its potential as a cognitive research tool. The work remains largely preclinical, and independent replication has been limited.
Regulatory and commercial contexts differ from clinical medicine. Dihexa is not approved as a drug by major agencies, and no published human trials establish its safety or efficacy. It is often sold as a research chemical labeled for laboratory use only. Suppliers may provide certificates of analysis, but purity and identity depend on the specific batch. Legal status varies by country and may treat such compounds as unapproved substances for human consumption.
While the production of alcohol is the most noteworthy by-product of yeast metabolism from a winemaking perspective, there are a number of other products that yeast produce that can be also influence the resulting wine. This includes glycerol which is produced when an intermediate of the glycolysis cycle (dihydroxyacetone) is reduced to "recharge" the NADH enzyme needed to continue other metabolic activities. This is usually produced early in the fermentation process before the mechanisms to reduce acetaldehyde into ethanol to recharge NADH becomes the cell's primary means of maintaining redox balance. As glycerol contributes increased body and a slightly sweet taste without increasing the alcohol level of the wine, some winemakers try to intentionally favor conditions that would promote glycerol production in wine. This includes selecting yeast strains that favor glycerol production (or allowing some wild yeast like Kloeckera and Metschnikowia to ferment), increased oxygen exposure and aeration as well as fermenting at higher temperatures. Glycerol production is also encouraged if most available acetaldehyde is made unavailable by binding with bisulfite molecules in the wine, but it would take a substantial amount of sulfur dioxide addition (far beyond legal limits) to prolong glycerol production beyond just these very nascent stages of fermentation. Other by-products of yeast include:
=== Time and frequency === Government standard frequency and time signal services operate time radio stations which continuously broadcast extremely accurate time signals produced by atomic clocks, as a reference to synchronize other clocks. Examples are BPC, DCF77, JJY, MSF, RTZ, TDF, WWV, and YVTO. One use is in radio clocks and watches, which include an automated receiver that periodically (usually weekly) receives and decodes the time signal and resets the watch's internal quartz clock to the correct time, thus allowing a small watch or desk clock to have the same accuracy as an atomic clock. Government time stations are declining in number because GPS satellites and the Internet Network Time Protocol (NTP) provide equally accurate time standards.
=== Introduction and History of DNA Legos === DNA origami has been used to assemble a range of two-dimensional and three-dimensional nanostructures; however, each different structure requires a new design and a new set of scaffold strand and staple strands. This limits scalability and structure yield efficiency. Researchers have developed “DNA brick” or “DNA Lego” technologies by making single stranded tiles (SSTs). SSTs allow for the production of larger structures without a scaffold strand and with the ease of arranging the predesigned blocks into bigger structures. Much like how actual Lego bricks allow specific assembly configurations, DNA Lego bricks bind at specific sites to form a range of shapes. Appropriate selection of blocks to include in an assembly mixture allows production of a variety of complex 3D shapes without a scaffold strand and without having to design an entirely different structure. With the DNA Lego brick approach, the DNA strand binds to neighboring strands to form a “brick”. By selecting subsets of strands to form a larger shape, researchers demonstrated that many 3D structures could be assembled from the same general set of components or bricks. The authors called this a “voxel-based” design strategy meaning that each 8-base pair interaction between bricks defines a voxel with dimensions 2.5 by 2.5 nm. Since each DNA interaction can be analogized to Lego construction, we can also claim one voxel corresponds to one stud Lego brick . This scaffold-free strategy has also been extended to larger multicomponent structures.
Sources: en.wikipedia.org
The industrial production of tryptophan is also biosynthetic and is based on the fermentation of serine and indole using either wild-type or genetically modified bacteria such as B. amyloliquefaciens, B. subtilis, C. glutamicum or E. coli. These strains carry mutations that prevent the reuptake of aromatic amino acids or multiple/overexpressed trp operons. The conversion is catalyzed by the enzyme tryptophan synthase.
=== Early business career === Heseltine began articles at Peat Marwick & Mitchell in January 1955. Whilst training as an accountant, he also built up a property business in the London property boom of the late 1950s. He and his Oxford roommate Ian Josephs had each inherited around £1,000 (around £23,000 at 2016 prices). They formed a property company called "Michian" (after their first names) and with the aid of a mortgage bought a 13-year lease on the so-called Thurston Court Hotel at 39 Clanricarde Gardens (near Notting Hill) for £3,750. They evicted the existing tenants so that Josephs' father could renovate the property and let out the rooms for a total rent of around £30 per week. A year later, they were able to sell the property at a profit, doubling their capital to £4,000. With the aid of a £23,000 mortgage, Heseltine and Josephs now bought a group of five adjacent houses for £27,000 in Inverness Terrace, Bayswater. They arranged for some medical students to decorate and remodel the property into a 45-bedroom boarding house, which they called the "New Court Hotel". Heseltine would sometimes cook breakfast himself, although he rejects tales that he would get up early to mix margarine in with the butter. Many of the tenants were American servicemen who, he later recorded, were for the most part respectful but sometimes rowdy at weekends. Edward Heath, then a government whip whom he had met at the Oxford Union, was his referee when he applied for the Conservative Party Parliamentary Candidates' List in October 1956.
=== Symptoms of exposure === β-Amanitin may cause irritation of the respiratory tract, headache, dizziness, nausea, shortness of breath, coughing, insomnia, diarrhea, gastrointestinal disturbances, back pain, urinary frequency, liver and kidney damage, or death if ingested or inhaled. If β-Amanitin comes in contact with skin, it may cause irritation, burns, redness, severe pain, and could be absorbed through the skin, causing similar effects to exposure via inhalation and ingestion. Contact with the eyes may result in irritation, corneal burns, and eye damage. Persons with pre-existing skin, eye, or central nervous systems disorders, impaired liver, kidney, or pulmonary function may be more susceptible to the effects of this substance.
Sources: en.wikipedia.org
=== Free radical reactions === Free radicals, molecules with unpaired electrons, play a large role in most reactions of alkanes. Free radical halogenation reactions occur with halogens, leading to the production of haloalkanes. The hydrogen atoms of the alkane are progressively replaced by halogen atoms. The reaction of alkanes and fluorine is highly exothermic and can lead to an explosion. These reactions are an important industrial route to halogenated hydrocarbons. There are three steps:
As an AAS, ethylestrenol is an agonist of the androgen receptor (AR), similarly to androgens like testosterone and dihydrotestosterone (DHT). It has low estrogenic activity (via aromatization into ethylestradiol following transformation into norethandrolone), strong progestogenic activity, and a high ratio of anabolic to androgenic activity, similarly to other nandrolone derivatives. Like other 17α-alkylated AAS, ethylestrenol has a risk of hepatotoxicity.
Soldiers and ninja also used "pills", small ball-shaped medicinal rations consumed in emergencies or long missions, of which there were three types: hyorogan ("ration pills"), made with various flours, sugary substances, and spices to provide quick energy; kikatsugan ("hunger pills"), made with starchy ingredients to provide endurance; and suikitsugan ("thirst pills"), made from umeboshi, bakumondoto, and sugar to encourage saliva production. Tang dynasty soldiers ate primarily millet porridge, but before a deployment, they would have a large and elaborate banquet, with another large meal before a battle. Song dynasty soldiers were issued money for food and bought meat, vegetables, pickles, and salt locally. Grain supply issues meant they relied less on grain rations than in prior generations. During the Ming dynasty, sesame seed cakes, which could last long periods of time, became standard military food and wheat began to take an important position in rations. The imperial government spent significant amounts of money on the military, investing more into supplying the army with food than previous dynasties. A system of military farmlands, comprising 10% of cultivated land, was organized to supply the army. The state assigned 10% to 20% of military households in each region with running military farms and provided them with seeds and tools to grow grain. Other farmers delivered grain to supplement bad growing seasons. In 1392, this system was designed to feed 1.2 million soldiers.
=== Cell culture === One of the key advantages of droplet-based microfluidics is the ability to use droplets as incubators for single cells. In addition, droplets can be applied for studies on embryogenesis of animals and plants. Devices capable of generating thousands of droplets per second open new ways to characterize cell populations, not only based on a specific marker measured at a specific time point but also based on cells' kinetic behavior such as protein secretion, enzyme activity or proliferation. Recently, a method was found to generate a stationary array of microscopic droplets for single-cell incubation that does not require the use of a surfactant.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide analog of angiotensin IV, often described as an HGF mimetic in research literature. It is studied for effects on synaptic connectivity in laboratory models. It is not an approved medication.
No, dihexa is a synthetic compound derived from the structure of angiotensin IV. Angiotensin IV occurs naturally, but dihexa has modifications that change its properties. It is not a standard dietary component.
The main hypothesis is that dihexa interacts with the hepatocyte growth factor system, possibly through c-Met signaling. This interaction may influence synaptogenesis and neuronal plasticity. The exact molecular target remains an active area of study.
Dihexa is a synthetic peptide-like compound studied primarily in preclinical models. It is often classified as an angiotensin IV analog and has been investigated for effects on neuronal connectivity. It is not an approved drug or dietary supplement.